To this end, we leveraged the recent finding that MMP-2 is the principal H3NT protease in the human U2OS osteosarcoma cell line with a native ChIP-Seq approach to map the genomic sites targeted for MMP-2 mediated H3NT proteolysis [24]. This evidence concerns the gene MMP2 and osteosarcoma.